| dc.contributor.author | Erenler, Ali Kemal | |
| dc.contributor.author | Yardan, Türker | |
| dc.date.accessioned | 2019-05-13T08:57:14Z | |
| dc.date.available | 2019-05-13T08:57:14Z | |
| dc.date.issued | 2015 | |
| dc.identifier.citation | Erenler, A. K., Yardan, T. (2015). Presepsin (sCD14-ST) as a biomarker of sepsis in clinical practice and in emergency department: a mini review. LaboratoriumsMedizin, 39(6), 367-372. | en_US |
| dc.identifier.issn | 0342-3026 | |
| dc.identifier.uri | https://doi.org/10.1515/labmed-2015-0072 | |
| dc.identifier.uri | https://hdl.handle.net/11491/877 | |
| dc.description.abstract | Presepsin is a 13-kDa protein that is a fragment of CD14 with truncated N-terminal, the receptor for lipopolysaccharide (LPS)/LPS-binding protein complexes. It is a novel marker being sought in many diseases such as sepsis, kidney failure, disseminated intravascular coagulation, etc. In this review, we aimed to clarify its utility in critical diseases and availability in critical care settings such as emergency departments and intensive care units. © 2015 by De Gruyter. | en_US |
| dc.language.iso | eng | |
| dc.publisher | Walter de Gruyter GmbH | en_US |
| dc.relation.isversionof | 10.1515/labmed-2015-0072 | en_US |
| dc.rights | info:eu-repo/semantics/closedAccess | en_US |
| dc.subject | Diagnostic Value | en_US |
| dc.subject | Presepsin | en_US |
| dc.subject | Sepsis | en_US |
| dc.title | Presepsin (sCD14-ST) as a biomarker of sepsis in clinical practice and in emergency department: A mini review | en_US |
| dc.type | article | en_US |
| dc.relation.journal | LaboratoriumsMedizin | en_US |
| dc.department | Hitit Üniversitesi, Tıp Fakültesi, Dahili Tıp Bilimleri Bölümü | en_US |
| dc.identifier.volume | 39 | en_US |
| dc.identifier.issue | 6 | en_US |
| dc.identifier.startpage | 367 | en_US |
| dc.identifier.endpage | 372 | en_US |
| dc.relation.publicationcategory | Makale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı | en_US |
